Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 18, Issue 2, Pages -Publisher
SPRINGER
DOI: 10.1007/s11910-018-0813-y
Keywords
Atrial fibrillation; Ischemic stroke; Intracerebral hemorrhage; Left atrial appendage closure
Categories
Funding
- Turkish Neurological Society
- National Institute of Health [NS083711]
Ask authors/readers for more resources
Purpose of Review This review aims to help neurologists managing atrial fibrillation (AF) patients who had an ischemic stroke and/or with intracranial hemorrhage (ICH) markers, therefore at high embolic/hemorrhagic risks. Recent Findings Implantable loop recorders have substantially improved the accuracy of AF detection. Recent research yielded a set of powerful neuroimaging markers that can stratify ICH risk. Direct oral anticoagulants (DOAC) are easier to use with a lower ICH risk than warfarin in a general AF population. Finally, the FDA-approved left atrial appendage closure (LAAC) with the WATCHMAN device provides an option without the need for life-long anticoagulation. Summary In this review, we introduce the concept of preventing both ischemic and hemorrhagic strokes in AF patients through accurate AF diagnosis and stratification of both embolic and ICH risks. LAAC can be considered in patients at higher hemorrhagic risks while warfarin/DOAC use should be individualized in the majority of AF patients at a low risk of bleeding.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available